Actions improving HPV vaccination uptake–Results from a national survey in Italy
C Giambi, M Del Manso, F D'Ancona, B De Mei… - Vaccine, 2015 - Elsevier
Abstract Background In Italy, HPV vaccination is offered to 11-year-old girls since 2007. In
2012 coverage was 69%. Strategies for offering and promoting HPV vaccination and …
2012 coverage was 69%. Strategies for offering and promoting HPV vaccination and …
Vaccination against human papillomavirus in Switzerland: simulation of the impact on infection rates
A Berchtold, PA Michaud, D Nardelli-Haefliger… - International journal of …, 2010 - Springer
Objectives Human papillomavirus (HPV) is a sexually transmitted infection of particular
interest because of its high prevalence rate and strong causal association with cervical …
interest because of its high prevalence rate and strong causal association with cervical …
Assessing incidence and economic burden of genital warts with data from a US commercially insured population
T Hoy, PK Singhal, VJ Willey… - Current medical research …, 2009 - Taylor & Francis
Objective: This study examined the incidence of and healthcare costs attributable to genital
warts within a large US commercially insured, geographically dispersed population …
warts within a large US commercially insured, geographically dispersed population …
Genital warts among 18-to 59-year-olds in the United States, national health and nutrition examination survey, 1999–2004
TH Dinh, M Sternberg, EF Dunne… - Sexually transmitted …, 2008 - journals.lww.com
Background: Genital warts are caused by human papillomavirus (HPV); over 90% are due to
HPV types 6 and 11. We determined the percentage of persons who reported having been …
HPV types 6 and 11. We determined the percentage of persons who reported having been …
HPV vaccination in France: uptake, costs and issues for the National Health Insurance
JP Fagot, A Boutrelle, P Ricordeau, A Weill… - Vaccine, 2011 - Elsevier
INTRODUCTION: Two vaccines for primary prevention of cervical cancer are available in
France, Gardasil® and Cervarix®, since 2007 and 2008 respectively. Currently, the French …
France, Gardasil® and Cervarix®, since 2007 and 2008 respectively. Currently, the French …
Health utilities lost and risk factors associated with HPV-induced diseases in men and women: the HPV Italian collaborative study group
A Marcellusi, A Capone, G Favato, FS Mennini… - Clinical …, 2015 - Elsevier
Purpose A complete economic evaluation requires accurate data concerning the resources
used, outcomes, and utilities (patient's preferences) to properly value the cost utility of …
used, outcomes, and utilities (patient's preferences) to properly value the cost utility of …
Impact of a single-age cohort human papillomavirus vaccination strategy in Catalonia, Spain: Population-based analysis of anogenital warts in men and women
M Brotons, L Monfil, E Roura, T Duarte-Salles… - Preventive …, 2020 - Elsevier
Extensive multiple-age cohort human papillomavirus (HPV) vaccination has proved to be
highly effective. We aimed to determine the 8-year population impact of a female single-age …
highly effective. We aimed to determine the 8-year population impact of a female single-age …
[HTML][HTML] Substantially reduced incidence of genital warts in women and men six years after HPV vaccine availability in Sweden
Background Between 2007 and 2011, opportunistic HPV-vaccination was available in
Sweden and partially subsidized to girls aged 13–17, reaching a∼ 30% overall coverage …
Sweden and partially subsidized to girls aged 13–17, reaching a∼ 30% overall coverage …
Burden of HPV related anogenital diseases in young women in Germany–an analysis of German statutory health insurance claims data from 2012 to 2017
M Reuschenbach, S Mihm, R Wölle… - BMC infectious …, 2020 - Springer
Background Most individuals are infected with human papillomavirus (HPV) at least once in
their lifetime. Infections with low-risk types can cause genital warts, whereas high-risk types …
their lifetime. Infections with low-risk types can cause genital warts, whereas high-risk types …
Impact of quadrivalent human papillomavirus vaccine in women at increased risk of genital warts burden: Population-based cross-sectional survey of Czech women …
M Petráš, V Adámková - Vaccine, 2015 - Elsevier
Background To assess the impact of a quadrivalent human papillomavirus vaccine (4HPV)
in women at increased risk of genital warts (GWs) acquisition. Methods The study was …
in women at increased risk of genital warts (GWs) acquisition. Methods The study was …